Bicocca Open Archive

Logo unimib boa
PESCI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.896
AS - Asia 7.903
EU - Europa 6.492
SA - Sud America 1.254
AF - Africa 207
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 6
Totale 30.783
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.549
SG - Singapore 2.897
CN - Cina 1.656
IT - Italia 1.149
DE - Germania 1.052
VN - Vietnam 1.051
HK - Hong Kong 996
RU - Federazione Russa 984
BR - Brasile 968
SE - Svezia 804
IE - Irlanda 622
GB - Regno Unito 367
UA - Ucraina 362
FR - Francia 360
IN - India 252
FI - Finlandia 222
CA - Canada 216
ID - Indonesia 193
AT - Austria 165
BD - Bangladesh 128
AR - Argentina 101
TR - Turchia 100
IQ - Iraq 95
KR - Corea 89
PK - Pakistan 80
MX - Messico 72
NL - Olanda 70
ZA - Sudafrica 65
DK - Danimarca 62
JP - Giappone 62
ES - Italia 55
SA - Arabia Saudita 54
CO - Colombia 44
PL - Polonia 43
BE - Belgio 34
EC - Ecuador 34
UZ - Uzbekistan 33
CZ - Repubblica Ceca 32
PH - Filippine 31
VE - Venezuela 31
CL - Cile 28
MA - Marocco 28
AE - Emirati Arabi Uniti 26
KE - Kenya 24
TN - Tunisia 20
AU - Australia 19
PY - Paraguay 19
MY - Malesia 17
CH - Svizzera 16
JO - Giordania 14
PE - Perù 14
PT - Portogallo 14
TH - Thailandia 14
AL - Albania 13
EG - Egitto 12
JM - Giamaica 12
NP - Nepal 12
OM - Oman 12
IR - Iran 11
KZ - Kazakistan 11
RO - Romania 11
CR - Costa Rica 10
KG - Kirghizistan 10
LB - Libano 10
DZ - Algeria 9
ET - Etiopia 9
IL - Israele 9
DO - Repubblica Dominicana 8
PA - Panama 8
UY - Uruguay 8
LT - Lituania 7
BO - Bolivia 6
BY - Bielorussia 6
GR - Grecia 6
HN - Honduras 6
NZ - Nuova Zelanda 6
PS - Palestinian Territory 6
BH - Bahrain 5
EE - Estonia 5
HU - Ungheria 5
MD - Moldavia 5
NG - Nigeria 5
RS - Serbia 5
SC - Seychelles 5
AZ - Azerbaigian 4
BG - Bulgaria 4
KH - Cambogia 4
MN - Mongolia 4
MU - Mauritius 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BB - Barbados 3
CG - Congo 3
GA - Gabon 3
GE - Georgia 3
NI - Nicaragua 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
BW - Botswana 2
CY - Cipro 2
Totale 30.739
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.538
Singapore 1.733
Ashburn 1.228
Hong Kong 986
Fairfield 907
Woodbridge 862
San Jose 857
Chandler 851
Frankfurt am Main 671
Dublin 603
Houston 594
Wilmington 552
New York 408
Dearborn 351
Jacksonville 345
Seattle 345
Ho Chi Minh City 293
Cambridge 291
Milan 260
Los Angeles 245
Princeton 240
Hanoi 237
Santa Clara 233
Beijing 227
The Dalles 221
Dallas 217
Chicago 214
Jakarta 154
Nanjing 145
Vienna 141
Shanghai 138
Lauterbourg 125
Hefei 119
Council Bluffs 117
Buffalo 116
Altamura 113
São Paulo 108
Lawrence 106
Helsinki 103
Moscow 103
Seoul 79
Munich 72
Guangzhou 71
San Diego 61
Toronto 61
Boardman 59
Lachine 56
Dong Ket 52
Tokyo 50
Nanchang 49
London 46
Orem 46
Da Nang 44
Fremont 42
Nuremberg 39
Jinan 37
Lappeenranta 36
Baghdad 35
Haiphong 34
Shenyang 34
Andover 33
Hebei 33
Atlanta 32
Brussels 32
Tashkent 31
Columbus 30
Phoenix 30
Dhaka 29
Montreal 29
Salt Lake City 29
Warsaw 29
Amsterdam 28
Rome 28
Tianjin 27
Brooklyn 26
Jiaxing 26
Johannesburg 26
Lissone 26
Stockholm 26
Lahore 25
Hải Dương 24
Monza 23
Rio de Janeiro 23
Riyadh 23
Turku 23
Belo Horizonte 22
Denver 22
Mexico City 22
Porto Alegre 22
Brasília 21
Brno 21
Changsha 21
Chennai 21
Hangzhou 21
Mumbai 20
Nairobi 20
Norwalk 20
Düsseldorf 19
Manchester 19
Ankara 18
Totale 20.100
Salva come PNG Salva come JPEG
Nome #
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 497
Progressive fibrosing interstitial lung diseases: prevalence and characterization in two Italian referral centers 425
Noninvasive ventilation weaning in acute hypercapnic respiratory failure due to COPD exacerbation: A real-life observational study 420
Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights 416
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 405
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection 388
Delirium symptoms during hospitalization predict long-term mortality in patients with severe pneumonia 367
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 361
Rehospitalization for pneumonia after first pneumonia admission: Incidence and predictors in a population-based cohort study 346
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study 346
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 343
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone 338
Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential 331
Prolonged exposure to welding fumes as a novel cause of systemic iron overload 330
Response to: Comment on "Noninvasive Ventilation Weaning in Acute Hypercapnic Respiratory Failure due to COPD Exacerbation: A Real-Life Observational Study" 326
Regional differences in bronchial reactivity assessed by respiratory impedance 320
Corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A single center experience and literature review 320
Non-specific interstitial pneumonia and features of connective tissue disease: What are the consequences of a different point of view? 318
Clinical phenotypes in adult patients with bronchiectasis 313
Interstitial pneumonia with autoimmune features: an additional risk factor for ARDS? 308
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 307
Management of acute respiratory failure in interstitial lung diseases: Overview and clinical insights 306
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases 304
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 302
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis 297
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 297
Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia 296
Characterization of bronchiectasis in the elderly 295
Impact of traffic-related air pollution on pulmonary oxidative stress 294
Dyspnea in crackling lungs 293
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study 289
Renal involvement in Churg-Strauss syndrome 288
Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy 285
Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life study 285
An unusual presentation of pulmonary lymphoma: When diffuse ground glass opacities can mean anything 285
Economic impact of anti-IL-5 agents in patients with severe eosinophilic asthma: A population-based cohort study 284
Multidimensional severity assessment in bronchiectasis: An analysis of seven European cohorts 282
C-arm cone-beam CT-guided transthoracic lung core needle biopsy as a standard diagnostic tool 280
Influenza A/H1N1 severe pneumonia: Novel morphocytological findings in bronchoalveolar lavage 279
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 279
Allergic bronchopulmonary aspergillosis screening in bronchiectasis: Is there always a precise answer to a clear question? 277
Macrolidi a lungo termine nella broncopneumopatia cronica ostruttiva 276
Can healthcare utilization data reliably capture cases of chronic respiratory diseases? A cross-sectional investigation in Italy 271
HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome 270
Psychometric properties and minimal important differences of SF-36 in Idiopathic Pulmonary Fibrosis 270
Effectiveness and economic impact of Dupilumab in asthma: a population-based cohort study 269
Progression of obstructive ventilatory disorder in Fabry disease: Only a matter of time? 268
Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study 266
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study 265
Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity 261
Differences between acute exacerbations of idiopathic pulmonary fibrosis and other interstitial lung diseases 261
A 61-year-old female with chronic cough and purulent sputum 258
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study 253
Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist 253
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 251
162. Cluster analysis to explore clinical subclassification of eosinophilic granulomatosis with polyangiitis (churg–strauss) 250
Il lavaggio broncoalveolare nelle pneumopatie infiltrative diffuse 247
Metallic elements in exhaled breath condensate of patients with interstitial lung diseases 242
Diaphragm ultrasonography in the management of patients with amyotrophic lateral sclerosis 241
Short-term Evolution of Nutritional Status in Patients with Idiopathic Pulmonary Fibrosis 240
Geriatric multidimensional assessment for elderly patients with acute respiratory diseases 238
Persistence with inhaled corticosteroids reduces the risk of exacerbation among adults with asthma: A real-world investigation 238
History of lung volume reduction procedures 238
Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis 236
The management of community-acquired pneumonia in the elderly 235
Molecular biomarkers in idiopathic pulmonary fibrosis: State of the art and future directions 235
Alpha glucocorticoid receptor expression in different experimental rat models of acute lung injury 234
Clinical course of IPF in Italian patients during 12 months of observation: results from the FIBRONET observational study 234
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 234
Pirfenidone in real life: A retrospective observational multicentre study in Italian patients with idiopathic pulmonary fibrosis 231
Feasibility of CPAP application and variables related to worsening of respiratory failure in pregnant women with SARS-CoV-2 pneumonia: Experience of a tertiary care centre 230
Non-tuberculous Mycobacterial Pulmonary Disease: an Italian National Survey 229
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19 229
COPD: maximization of bronchodilation 227
Bronchoalveolar lavage in idiopathic pulmonary fibrosis: What does it tell us? 226
EBUS-TBNA nella patologia mediastino-polmonare: analisi retrospettiva dei primi 3 anni di attività di un singolo centro 223
Impact of N-acetyl-L-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study 223
Uterine carcinosarcoma metastatic to the lung as large-cell neuroendocrine carcinoma with synchronous sarcoid granulomatosis 219
Interstitial lung diseases in a lung cancer screening trial 217
Systemic sclerosis and outcome in intensive care unit: Do not close the door, open the right protocol 217
A case of ARDS associated with influenza A - H1N1 infection treated with extracorporeal respiratory support 215
Cardiovascular Structural and Functional Parameters in Idiopathic Pulmonary Fibrosis at Disease Diagnosis 210
Acute myocardial infarction versus other cardiovascular events in communityacquired pneumonia 208
Feasibility and clinical impact of a portable bi-level ventilation device in patients with severe chronic obstructive pulmonary disease and exertional dyspnea: preliminary results from a clinical series 208
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 207
Covid-19 and the role of smoking: The protocol of the multicentric prospective study COSMO-IT (covid19 and smoking in italy) 206
Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approach 203
The bronchiectasis severity index. An international derivation and validation study 201
Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis 201
Early recognition of airway obstruction in Fabry disease and correlation with dyspnea: A case series 200
Right ventricular reverse remodelling in Idiopathic Pulmonary Arterial Hypertension diagnosed during pregnancy: Is it possible? 199
Optimization of ventilator setting by flow and pressure waveforms analysis during noninvasive ventilation for acute exacerbations of COPD: a multicentric randomized controlled trial 196
Circadian rhythm of COPD symptoms in clinically based phenotypes. Results from the STORICO Italian observational study 195
Alveolar Diseases 191
Respiratory system involvement in ANCA-associated systemic vasculitides 190
Respiratory viruses in stable bronchiectasis: A multicenter evaluation in Northern Italy 189
Long-term macrolides in diffuse interstitial lung diseases 188
Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis 187
Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia 187
Surgical and endoscopic treatment for COPD: Patients selection, techniques and results 187
Totale 26.795
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.985
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.985
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021414 0 0 0 0 0 0 0 0 0 0 169 245
2021/20221.968 194 206 232 210 109 161 65 95 75 140 156 325
2022/20233.101 347 865 350 289 186 471 36 179 215 22 82 59
2023/20241.995 52 61 107 97 247 551 367 90 122 33 32 236
2024/20254.818 282 524 250 205 411 247 258 226 520 827 399 669
2025/202610.368 1.358 611 819 1.159 1.308 675 1.733 550 1.045 967 143 0
Totale 31.478